Opportunity radar
4,186,134 patents indexed · 165,974,948 citations · issued 2005-01-04 → 2026-05-05
Showing50 of 30,058
Pharma (A61K)Therapy methods (A61P)Med devices (A61M)Agriculture (A01)Hand tools (B25)Consumer (A47)Energy (H01M)AI / ML (G06N)
| Patent # | Title | Assets | Issued | Expires | Fwd cites | Score |
|---|---|---|---|---|---|---|
| 12616722 | Treatment of immune disorders | 🖼🧊📄§ | 2026-05-05 | 2045-01-17 | 0 | 31 |
| 12616725 | Bifidobacterium breve IDCC 4401 strain and its dead cell ID-BBR4401 having excellent acid tolerance and bile tolerance and prophylactic or therapeutic effect on dyslipidemia | 🖼🧊📄§ | 2026-05-05 | 2042-12-30 | 0 | 31 |
| 12616724 | Pharmaceutical composition for preventing or treating intestinal damage comprising Leuconostoc citreum strain as active ingredient | 🖼🧊📄§ | 2026-05-05 | 2042-02-07 | 0 | 31 |
| 12616731 | Process for enhancing organoleptic properties of natural products and natraceuticals thereof | 🖼🧊📄§ | 2026-05-05 | 2041-09-22 | 0 | 31 |
| 12616732 | Peptides for treatment of medical disorders | 🖼🧊📄§ | 2026-05-05 | 2042-07-11 | 0 | 31 |
| 12616746 | Infectious disease antigens and vaccines | 🖼🧊📄§ | 2026-05-05 | 2042-10-03 | 0 | 31 |
| 12616753 | HSP70 inhibitors and methods of using same | 🖼🧊📄§ | 2026-05-05 | 2041-03-30 | 0 | 31 |
| 12616752 | Pharmaceutical compositions comprising meloxicam | 🖼🧊📄§ | 2026-05-05 | 2045-06-05 | 0 | 31 |
| 12618838 | Single domain VHH antibodies against SARS-CoV-2 virus | 🖼🧊📄§ | 2026-05-05 | 2042-11-15 | 0 | 31 |
| 12618031 | Delivery devices | 🖼🧊📄§ | 2026-05-05 | 2041-06-24 | 0 | 31 |
| 12616761 | CXCR4-targeting compounds | 🖼🧊📄§ | 2026-05-05 | 2044-06-27 | 0 | 31 |
| 12616684 | Pulmonary fibrosis medicine containing pyrazole derivative | 🖼🧊📄§ | 2026-05-05 | 2041-03-23 | 0 | 31 |
| 12616705 | Use of cannabinoids in the treatment of Angelman syndrome | 🖼🧊📄§ | 2026-05-05 | 2043-05-02 | 0 | 31 |
| 12616706 | Compositions and methods of use comprising substances with neural plasticity actions administered at non-psychedelic/psychotomimetic dosages and formulations | 🖼🧊📄§ | 2026-05-05 | 2040-03-06 | 0 | 31 |
| 12616741 | Therapeutic combination comprising a pulmonary surfactant and a steroid for the prophylaxis of BPD | 🖼🧊📄§ | 2026-05-05 | 2041-03-17 | 0 | 31 |
| 12616666 | Coenzyme Q10 formulations in the treatment and prevention of epidermolysis bullosa | 🖼🧊📄§ | 2026-05-05 | 2042-07-13 | 0 | 31 |
| 12616669 | Methods and chemical compositions for treating skin conditions by providing long lasting skin pH control for improving skin barrier function | 🖼🧊📄§ | 2026-05-05 | 2045-08-27 | 0 | 31 |
| 12616657 | Cell-targeted nanoparticles to inhibit RNA cargo | 🖼🧊📄§ | 2026-05-05 | 2041-02-26 | 0 | 31 |
| 12616655 | Topical antibiotic containing pharmaceutical composition for bacterial infections and wound healing | 🖼🧊📄§ | 2026-05-05 | 2040-10-19 | 0 | 31 |
| 12616747 | Stabilized beta-coronavirus antigens | 🖼🧊📄§ | 2026-05-05 | 2042-12-02 | 0 | 31 |
| 12616727 | Compositions, systems, and methods for improving health | 🖼🧊📄§ | 2026-05-05 | 2043-06-29 | 0 | 31 |
| 12616712 | Sting agonist comprising exosomes for treating neuroimmunological disorders | 🖼🧊📄§ | 2026-05-05 | 2040-09-24 | 0 | 31 |
| 12616692 | Method of achieving HIV viral remission using long-acting antiretroviral agents | 🖼🧊📄§ | 2026-05-05 | 2041-06-30 | 0 | 31 |
| 12616671 | Use of rigosertib to treat RNA virus infections | 🖼🧊📄§ | 2026-05-05 | 2041-05-28 | 0 | 31 |
| 12617813 | Glycosylated histone deacetylase inhibitors and methods of making and using the same | 🖼🧊📄§ | 2026-05-05 | 2041-12-28 | 0 | 31 |
| 12617773 | Azetidin-3-ylmethanol derivatives as CCR6 receptor modulators | 🖼🧊📄§ | 2026-05-05 | 2041-04-30 | 0 | 31 |
| 12617774 | Substituted indole compounds and methods of use thereof | 🖼🧊📄§ | 2026-05-05 | 2045-05-30 | 0 | 31 |
| 12617797 | Substituted pyrazolo [1,5-a]pyrimidines having multimodal activity against pain | 🖼🧊📄§ | 2026-05-05 | 2041-05-20 | 0 | 31 |
| 12611375 | Injectable slurries and methods of manufacturing the same | 🖼🧊📄§ | 2026-04-28 | 2044-04-17 | 0 | 31 |
| 12611390 | Methods and chemical compositions for treating skin conditions by providing long lasting skin PH control for improving skin barrier function | 🖼🧊📄§ | 2026-04-28 | 2045-08-21 | 0 | 31 |
| 12611389 | Compositions and methods to reduce or eliminate nasal biofilms and mucus barriers allowing sodium pyruvate to increase the synthesis of nitric oxide and eliminate nasal infections and their toxins that cause lung, nerve and brain damage | 🖼🧊📄§ | 2026-04-28 | 2045-08-15 | 0 | 31 |
| 12611388 | Weight loss formulation and methods | 🖼🧊📄§ | 2026-04-28 | 2042-05-27 | 0 | 31 |
| 12611386 | Extended release pharmaceutical formulation | 🖼🧊📄§ | 2026-04-28 | 2041-09-22 | 0 | 31 |
| 12611387 | Compound and composition for inducing neuroprotection | 🖼🧊📄§ | 2026-04-28 | 2041-05-20 | 0 | 31 |
| 12611395 | Use of carbamate compound for preventing or treating trigeminal neuralgia | 🖼🧊📄§ | 2026-04-28 | 2041-12-02 | 0 | 31 |
| 12611394 | Use of ginkgolide a in the treatment of autism | 🖼🧊📄§ | 2026-04-28 | 2040-09-24 | 0 | 31 |
| 12611393 | Treatment of pain by targeting NR4A1 | 🖼🧊📄§ | 2026-04-28 | 2040-08-31 | 0 | 31 |
| 12611403 | Combined pharmaceutical composition of c-Met kinase inhibitor and anti-PD-L1 antibody | 🖼🧊📄§ | 2026-04-28 | 2041-06-01 | 0 | 31 |
| 12611404 | Aza-aryl 1H-pyrazol-1-yl benzene sulfonamides | 🖼🧊📄§ | 2026-04-28 | 2041-10-29 | 0 | 31 |
| 12611402 | Compounds and their use for the treatment of ALPHA1-antitrypsin deficiency | 🖼🧊📄§ | 2026-04-28 | 2042-06-13 | 0 | 31 |
| 12611406 | Oxopiperazine derivatives for the treatment of cancer | 🖼🧊📄§ | 2026-04-28 | 2041-06-18 | 0 | 31 |
| 12611416 | Methods of treating ischemic stroke at risk for cerebral or cerebellar edema | 🖼🧊📄§ | 2026-04-28 | 2045-05-13 | 0 | 31 |
| 12611446 | Cannabinoid product for improving musculoskeletal health | 🖼🧊📄§ | 2026-04-28 | 2040-09-30 | 0 | 31 |
| 12611437 | Composition for preventing or treating tinnitus comprising Vitis viniferaleaf extract as active ingredient | 🖼🧊📄§ | 2026-04-28 | 2040-02-12 | 0 | 31 |
| 12611436 | AAV transfer cassette | 🖼🧊📄§ | 2026-04-28 | 2040-10-16 | 0 | 31 |
| 12611449 | Individualized vaccines for cancer | 🖼🧊📄§ | 2026-04-28 | 2039-07-23 | 0 | 31 |
| 12611418 | Methods for treating anxiety disorders, headache disorders, and eating disorders with psilocybin | 🖼🧊📄§ | 2026-04-28 | 2045-08-11 | 0 | 31 |
| 12613245 | Methods for detecting and inhibiting brain metastasis | 🖼🧊📄§ | 2026-04-28 | 2040-10-15 | 0 | 31 |
| 12612631 | Small RNA medicament for prevention and treatment of inflammation-related diseases and combination thereof | 🖼🧊📄§ | 2026-04-28 | 2038-12-25 | 0 | 31 |
| 12612629 | Duchenne muscular dystrophy-related exonic splicing enhancer, sgRNA and gene editing tool, and applications | 🖼🧊📄§ | 2026-04-28 | 2040-09-30 | 0 | 31 |